Form 8-K - Current report:
SEC Accession No. 0001815776-25-000077
Filing Date
2025-12-12
Accepted
2025-12-12 16:15:09
Documents
12
Period of Report
2025-12-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K lenz-20251212.htm   iXBRL 8-K 25666
  Complete submission text file 0001815776-25-000077.txt   146313

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lenz-20251212.xsd EX-101.SCH 1770
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lenz-20251212_lab.xml EX-101.LAB 23433
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lenz-20251212_pre.xml EX-101.PRE 13570
15 EXTRACTED XBRL INSTANCE DOCUMENT lenz-20251212_htm.xml XML 3041
Mailing Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075
Business Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075 858-925-7000
LENZ Therapeutics, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40532 | Film No.: 251568261
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)